Elsevier

Sleep Medicine

Volume 51, November 2018, Pages 153-166
Sleep Medicine

Original Article
Efficacy of brief behavioral treatment for insomnia in older adults: examination of sleep, mood, and cognitive outcomes

https://doi.org/10.1016/j.sleep.2018.05.018Get rights and content

Highlights

  • Research on the efficacy of brief behavioral treatment for insomnia (BBTi) is limited.

  • Older adults completed four sessions of BBTi or self-monitoring control.

  • BBTi improved sleep onset, wake after sleep onset, sleep efficiency, and sleep quality.

  • BBTi did not improve cognition, and it reduced depression to a degree same as that of controls.

  • BBTi is an efficacious intervention for reducing insomnia symptoms in older adults.

Abstract

Objective

The aim of the present study was to examine the effects of a brief behavioral intervention for insomnia (BBTi) on sleep parameters, mood, and cognitive functioning in older adults.

Methods

Older adults (aged 65 years or more) underwent four weekly sessions of BBTi or self-monitoring control (SMC). Participants completed 14 days of sleep diaries and actigraphy measuring sleep onset latency (SOL), wake after sleep onset (WASO), total sleep time (TST), sleep efficiency (SE), and sleep quality ratings at baseline, post-treatment, and three month follow-up. Participants also completed mood scales (Geriatric Depression Scale [GDS]; Beck Depression Inventory-II; and State Trait Anxiety Inventory) and neuropsychological testing (measuring global cognition, language, memory, attention and processing speed, and executive function) at the three timepoints.

Results

Significant condition (BBTi vs. SMC) x time (baseline vs. post-treatment vs. follow-up) interactions revealed that BBTi improved relative to baseline in sleep diary-reported SOL, WASO, SE, and sleep quality, and these improvements were maintained at follow-up. SMC showed no change in these measures. A main effect of time showed that actigraphy-measured WASO improved from baseline for both BBTi and SMC at post-treatment. A main effect of time revealed that both BBTi and SMC patients endorsed fewer GDS symptoms relative to baseline at post-treatment and follow-up. We observed no change in performance on neuropsychological measures.

Conclusions

A four-week BBTi is an efficacious intervention for reducing insomnia symptoms in older adults. BBTi does not selectively improve mood or cognitive functioning. Future work should examine effects of BBTi on physiological measures of sleep architecture and day-to-day cognition.

Clinical Trial Identifer

NCT02967185.

Introduction

Insomnia is defined as difficulty initiating, maintaining, or experiencing nonrestorative sleep concurrent with distress or impairment in critical areas of everyday functioning, such as increased daytime fatigue, negative mood, and poor concentration [1]. Given that the amount of deep sleep (ie, slow wave and REM) declines with age [2], older adults are at a greater risk of midnight and early morning awakenings than younger individuals [3]. Moreover, insomnia is the most common sleep disorder in later life and impacts approximately 20–50% of older adults [≥65 years; [4], [5]]. While pharmacological treatment of insomnia in old age continues to be much more common, there is a robust body of evidence that psychological treatments for insomnia: generally called cognitive behavioral therapy for insomnia (CBT-I). These are highly efficacious [6] and can result in fewer adverse side effects [7] and are preferred [8] relative to pharmacological treatments. Furthermore, the American College of Physicians now recommends CBT-I as the first line of treatment for older adults with insomnia [9]. The majority of the studies on CBT-I to date have utilized relatively lengthy treatment protocols (weekly one-hour individual sessions for 6–8 weeks). The current study investigates the impact of brief behavioral treatment for insomnia (BBTi) on sleep, mood, and cognitive outcomes in older adults.

Despite the fact that approximately 80–90% of patients with insomnia also have a concurrent medical or psychological diagnosis [10], previous research on older adults has focused on insomnia in isolation. This was mainly due to the belief that insomnia symptoms that occurred in the context of another medical or psychological condition were “secondary” to that condition. Thus, the treatment focus was on the “primary” nonsleep condition, and the sleep problem was not typically treated independently [11]. However, there has been a significant shift in the clinical and research conceptualization of insomnia based on evidence that was outlined in a 2005 State-of-the-Science Conference regarding chronic insomnia [12]. Based on the recommendations from that conference, insomnia is now conceptualized as comorbid, rather than secondary in nature when there are concurrent medical or psychological diagnoses. There is a growing body of empirical research that indicates that insomnia can be independently treated without the need to first resolve the comorbid condition [13], [14], [15], [16], [17]. However, many studies to date among older adults have specifically excluded individuals on the basis of the presence of comorbid medical or psychological conditions [18], [19], [20]. Given that conditions such as chronic pain, depression, and anxiety are particularly common among older individuals with chronic insomnia [21], a strength of the current study is its inclusion of older individuals with a wide variety of comorbid medical and psychological symptoms. Notably, results obtained for these individuals are more likely to be representative of the average older adult population with insomnia.

The efficacy of CBT-I is well established [22], [23], and research has shown that it is superior to benzodiazepine and nonbenzodiazepine sleeping medications for the long-term treatment of insomnia [24]. However, determining the critical elements of the intervention is not possible when delivering a multicomponent treatment such as CBT-I. A full decomposition study on CBT-I has not been performed to determine the most impactful elements of the treatment, but there is evidence to suggest that more succinct models of psychological treatment for insomnia may be as efficacious as longer treatment schedules among older adults [22], [25]. Several techniques including stimulus control, progressive muscle relaxation, and the cognitive technique of paradoxical intention have been judged to meet criteria as well-established standalone treatments [23]. In addition, there is some evidence to suggest that cognitive therapy can be efficacious as a standalone treatment [26]. Sleep hygiene has not been previously found to be an efficacious standalone treatment [27], whereas relaxation and stimulus control have been found to be efficacious [6], [28]. Of CBT-I studies to date in older adults, three have utilized either a more brief in-person behavioral intervention of four sessions [25], [29] or a brief mixed in-person and telephone intervention of four sessions [30]. In the Palleson and colleagues study, a comparison of sleep hygiene and relaxation, sleep hygiene and stimulus control, and wait-list control found no difference in efficacy between the two treatment approaches, and both groups showed significant improvement compared to a waitlist group [25]. In Buysse and colleagues’ study, BBTi resulted in significant improvements in subjective and objective sleep measures relative to a control group that read brochures on sleep, aging, and sleep hygiene; however, the two groups were not matched on time spent with a therapist [30]. Similarly, in Lovato and colleagues study evaluating small group-session BBTi, improvements in subjective wake after sleep onset [WASO], sleep efficiency [SE], and daytime functioning were observed relative to a waitlist control group at post-treatment relative to baseline [29]. The present study adds to this sparse literature by testing the impact of in-person delivery of a four-session BBTi protocol on primary subjective and objective sleep outcomes compared to a self-monitoring control (SMC) that provided equivalent contact with study personnel.

Chronic insomnia has been linked to worse mood across the lifespan [31], [32], [33], with nearly 90% of participants with insomnia symptoms in one epidemiological study reporting symptoms of depression or anxiety [33]. While sleep disturbance is included in the diagnostic criteria for numerous mood and anxiety disorders, insomnia often develops an independent course during time as patients adopt compensatory behaviors and thought patterns intended to help improve their sleep, but which often have the opposite effect. With time, the insomnia is maintained by these factors rather than those that contributed to its onset [34]. Additionally, there is considerable evidence that insomnia is a risk factor for the subsequent development of depressive symptoms [32], [35]. Daily patterns of covariation have been noted between disturbed sleep and daytime functioning. For instance, greater subjective sleep disturbance has shown to predict worse mood [36] and global daytime functioning the next day [37]. While the underlying mechanisms for this relationship remain to be determined, it is clear that sleep and mood factors are highly related. There is some evidence to suggest that the use of CBT-I in the treatment of insomnia can result in improvements in depression and anxiety symptoms [38], [39]. However, these findings have not been consistent across the existing research and deserve further investigation to determine whether brief interventions for insomnia can result in improvements in other mental health symptoms.

Changes in cognition concurrent with aging have been documented across a number of domains including memory, attention, processing speed, and executive functioning. In addition, there is evidence that self-reported sleep disturbance among older adults is related to cognitive performance impairments in the domains of memory, attention, and executive function [40], [41], [42], [43]. While there is evidence to suggest a relationship between subjective sleep disruption and cognitive functioning [44], results across numerous studies have not been consistent among cross-sectional and longitudinal designs, with many studies finding no meaningful differences between those with and without insomnia [45], [46], [47]. These inconsistent findings may be partially explained by small sample sizes, methodological differences in the assessment of insomnia symptoms, and the different populations under study [45], [47]. The relationship between sleep disruption and cognitive impairment may be moderated by the relative amount of cognitive reserve/resilience, measured by proxy using educational attainment, such that individuals with greater premorbid education display less cognitive impairment in the presence of sleep onset or maintenance difficulties [48]. In addition, independent of the effects of health problems or the use of sleeping medication, chronic insomnia has been found to be associated with an increased risk of cognitive decline among older men compared to those without insomnia but not among older women [49]. Results from a secondary analysis in Buysse and colleagues BBTi study supported these suggestions and showed that the intervention did not improve executive function or episodic memory with time or relative to an informational control group [50]. However, the authors note that the length of treatment (two in-person and two telephone sessions) and/or the follow-up period may not have been long enough to detect cognitive changes [50]. At this time, there is no sufficient evidence to conclude that treatment of insomnia symptoms will result in improvements in cognitive functioning [51]. However, there is a clear need for additional research into the potential effects of sleep disruption on cognitive functioning among older adults.

In sum, the present study investigated the effect of a BBTi in older adults with insomnia on sleep, cognition, and mood outcomes immediately following treatment and at a three month follow-up. We hypothesized that compared to SMCs, older adults with insomnia who undergo BBTi would exhibit significant improvements in self-reported sleep quality and self-reported and actigraphy-measured outcomes related to insomnia [sleep onset latency (SOL), WASO, total sleep time (TST), and SE], and those gains would either be maintained or further improved at three month follow-up. We further hypothesized that compared to SMC, older adults with insomnia who undergo BBTi would exhibit significant improvements in anxiety and depression immediately following treatment, and those gains would either be maintained or further improved at three month follow-up. Finally, given lack of prior conclusive findings regarding the relationship between insomnia and cognition, it is unclear whether, compared to SMC, older adults with insomnia who undergo BBTi would exhibit significant improvements in cognitive performance across various domains (ie, global cognition, attention/processing speed, memory, language and executive functioning). Given the large range of sleep (both self-reported and objective), cognition, and mood evaluations, results of the present study will provide insight into the mechanisms underlying the efficacy of BBTi and/or help determine whether sleep disruption is an important pathway associated with mood and cognition in older adults.

Section snippets

Overview

The present trial compared changes in sleep, mood, and cognitive performance in older adults with insomnia immediately and three months following four weeks of BBTi or SMC. The University of Florida's Institutional Review Board (IRB-02) approved the trial protocol. All participants gave written informed consent to participate. This trial is registered at www.clinicaltrials.gov (NCT02967185).

Participants

Participants (N = 62) were recruited from Gainesville and surrounding areas through newspaper and other

Treatment adherence

Of the 62 participants who were randomized, eight declined and did not participate in a single weekly session. Chi-square analyses to assess for systematic group differences in this baseline dropout rate were not significant [χ2 (1, N = 62) = 2.61, p = 0.11]. Of the remaining 54 participants, all completed the first two weeks, three dropped out after the second session, and one dropped out after the third session. The remaining participants completed all sessions (n = 50) and the majority of

Discussion

The present randomized clinical trial examined the effectiveness of a four week BBTi relative to the SMC group in improving (at post-treatment) and maintaining (at three month follow-up) sleep diary, actigraphy, mood, and neuropsychological outcomes in older adults with chronic insomnia.

Financial support

The project described was supported by Award Number AG024459 (Christina S. McCrae, PhD., PI) from the National Institute on Aging (NIA). Additional support was provided by an institutional training grant award number AG020499 (Michael Marsiske, PhD, Director) and Award Number K23AG049955 (Joseph Dzierzewski, PhD, PI). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIA.

References (101)

  • D. Riemann et al.

    Primary insomnia: a risk factor to develop depression?

    J Affect Disord

    (2003)
  • G. Belleville et al.

    Meta-analytic review of the impact of cognitive-behavior therapy for insomnia on concomitant anxiety

    Clin Psychol Rev

    (2011)
  • C.H. Bastien et al.

    Cognitive performance and sleep quality in the elderly suffering from chronic insomnia: relationship between objective and subjective measures

    J Psychosom Res

    (2003)
  • É. Fortier-Brochu et al.

    Insomnia and daytime cognitive performance: a meta-analysis

    Sleep Med Rev

    (2012)
  • B.W. Riedel et al.

    Insomnia and daytime functioning

    Sleep Med Rev

    (2000)
  • J.M. Dzierzewski et al.

    Sleep and cognition in older adults

    Sleep Med Clin

    (2018)
  • J.A. Yesavage et al.

    Development and validation of a geriatric depression screening scale: a preliminary report

    J Psychiatr Res

    (1983)
  • K.L. Lichstein et al.

    Fair tests of clinical trials: a treatment implementation model

    Adv Behav Res Ther

    (1994)
  • R.I. Kabacoff et al.

    Psychometric properties and diagnostic utility of the Beck Anxiety Inventory and the State-Trait Anxiety Inventory with older adult psychiatric outpatients

    J Anxiety Disord

    (1997)
  • M.F. Folstein et al.

    “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician

    J Psychiatr Res

    (1975)
  • T.N. Tombaugh

    Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS

    Arch Clin Neuropsychol

    (2005)
  • S. Joy et al.

    Speed and memory in the WAIS-III Digit Symbol—coding subtest across the adult lifespan

    Arch Clin Neuropsychol

    (2004)
  • B.N. Axelrod et al.

    Concurrent validity of the MAE visual naming test

    Arch Clin Neuropsychol

    (1994)
  • J.L. Flanagan et al.

    Test-retest reliability of three aphasia tests: Performance of non-brain-damaged older adults

    J Commun Disord

    (1997)
  • L.H. Lacritz et al.

    The hopkins verbal learning test and CVLT: a preliminary comparison

    Arch Clin Neuropsychol

    (1998)
  • V. Elderkin-Thompson et al.

    Executive dysfunction and visuospatial ability among depressed elders in a community setting

    Arch Clin Neuropsychol

    (2004)
  • D.W. Loring et al.

    Psychometric construction of the Rey-Osterrieth complex figure: methodological considerations and interrater reliability

    Arch Clin Neuropsychol

    (1990)
  • E. Strauss et al.

    A comparison of the Rey and Taylor figures

    Arch Clin Neuropsychol

    (1990)
  • E. Ferrario et al.

    Mini-mental state examination and Wechsler memory scale subtest of logical memory: correlation in an over 70-year-old population

    Arch Gerontol Geriatr

    (1998)
  • American Psychiatric Association

    Diagnostic and statistical manual of mental disorders (DSM-5®)

    (2013)
  • D.L. Bliwise

    Sleep in normal aging and dementia

    Sleep J Sleep Res Sleep Med

    (1993)
  • M.M. Ohayon et al.

    Meta-analysis of quantitative sleep parameters from childhood to old age in healthy individuals: developing normative sleep values across the human lifespan

    Sleep

    (2004)
  • D.J. Foley et al.

    Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years

    Sleep

    (1999)
  • M.M. Ohayon et al.

    How age and daytime activities are related to insomnia in the general population: consequences for older people

    J Am Geriatr Soc

    (2001)
  • C.M. Morin et al.

    Psychological and behavioral treatment of insomnia:update of the recent evidence (1998-2004)

    Sleep

    (2006)
  • S. Omvik et al.

    Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial

    JAMA

    (2006)
  • N. Vincent et al.

    Treatment preference and patient satisfaction in chronic insomnia

    Sleep

    (2001)
  • A. Qaseem et al.

    Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians

    Ann Intern Med

    (2016)
  • D.J. Taylor et al.

    Comorbidity of chronic insomnia with medical problems

    Sleep

    (2007)
  • F. Zorick et al.

    Evaluation and management of insomnia: an overview

    Princ Pract Sleep Med (3rd ed). Philadelphia: Saunders

    (2000)
  • NIH

    State of the Science conference statement on manifestations and management of chronic insomnia in adults, June 13-15, 2005

    Sleep

    (2005)
  • C. Quesnel et al.

    Efficacy of cognitive-behavioral therapy for insomnia in women treated for nonmetastic breast cancer

    J Consult Clin Psychol

    (2003)
  • B. Rybarczyk et al.

    A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults

    J Consult Clin Psychol

    (2005)
  • C.M. Morin et al.

    Behavioral and cognitive treatments of geriatric insomnia

    J Consult Clin Psychol

    (1988)
  • K.L. Lichstein et al.

    Relaxation and sleep compression for late-life insomnia: a placebo-controlled trial

    J Consult Clin Psychol

    (2001)
  • B.W. Riedel et al.

    Sleep compression and sleep education for older insomniacs: self-help versus therapist guidance

    Psychol Aging

    (1995)
  • M.R. Irwin et al.

    Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age

    Health Psychol

    (2006)
  • P. Montgomery et al.

    Cognitive behavioural interventions for sleep problems in adults aged 60+

    Cochrane Database Syst Rev

    (2003)
  • M.D. Mitchell et al.

    Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review

    BMC Fam Pract

    (2012)
  • N. Lovato et al.

    Evaluation of a brief treatment program of cognitive behavior therapy for insomnia in older adults

    Sleep

    (2014)
  • Cited by (43)

    • Cognitive-behavioral therapy for late-life insomnia

      2023, Handbook of Lifespan Cognitive Behavioral Therapy: Childhood, Adolescence, Pregnancy, Adulthood, and Aging
    View all citing articles on Scopus
    View full text